Biohaven Ltd.
BHVN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001935979
No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 297 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Biohaven Ltd. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 279
- +9 vs. Q4 2025
- Shares held
- 144.4M
- +26.7M (+22.7%) vs. Q4 2025
- Total value
- $1.22B
- −$107.2M (−8.1%) vs. Q4 2025
- New holders
- 44
- 119 more added
- Sold out
- 35
- 64 more reduced
5 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 297 | $2.13B |
| Q1 2026 | 279 | $1.22B |
| Q4 2025 | 275 | $1.40B |
| Q3 2025 | 266 | $1.28B |
| Q2 2025 | 251 | $1.24B |
| Q1 2025 | 267 | $2.24B |
| Q4 2024 | 258 | $3.51B |
| Q3 2024 | 257 | $4.34B |
| Q2 2024 | 228 | $2.90B |
| Q1 2024 | 245 | $4.09B |
| Q4 2023 | 220 | $3.09B |
| Q3 2023 | 188 | $1.61B |
| Q2 2023 | 189 | $1.45B |
| Q1 2023 | 180 | $921.1M |
| Q4 2022 | 183 | $882.3M |
| Q3 2022 | 277 | $9.26B |
| Q2 2022 | 330 | $8.96B |
| Q1 2022 | 306 | $7.58B |
| Q4 2021 | 284 | $8.55B |
| Q3 2021 | 250 | $8.17B |
| Q2 2021 | 223 | $5.80B |
| Q1 2021 | 225 | $4.10B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Biohaven Ltd.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alpha Wealth Funds, LLC | 0 | $0 | 0.00% | −19,400−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −15,239−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −22,951−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −9,250−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −6,935−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,946−100.0% | Sold out |
| MRP Capital Investments, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −786−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Westside Investment Management, Inc. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Catherine Avery Investment Management LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Iron Triangle Partners LP | – | – | – | – | Not filed |
| Oracle Investment Management Inc | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Motiv8 Investments LLC | – | – | – | – | Not filed |